Riskpilot← Back to searchSign inGet full accessAGIL HELSE AS
ASActiveOrg 992975032Sørkedalsveien 10A, 0369 OsloOther human health activities n.e.c. · NACE 8699Est. 200823 employeeswww.agilhelse.no
Revenue 2024
NOK 22M
+3% vs 2023
EBITDA margin
-17.2%
-1801% vs 2023
Equity ratio
-77.0%
Financial strength
Net profit 2024
NOK -3,3M
-400% vs 2023
| Revenue | NOK 22M | +3% |
| EBITDA | NOK -3,8M | -1801% |
| Net profit | NOK -3,3M | -400% |
| Total assets | NOK 7,5M | -7% |
| Equity | NOK -5,8M | -3029% |
| Employees | 23 | — |
Legal name
AGIL HELSE AS
Org number
992975032
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
13. august 2008
Share capital
NOK 64 847
Employees
23 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Forebyggende helsetjeneste for bedrifter og institusjoner, drive konsultativ virksomhet innenfor helse miljø og sikkerhet samt delta i virksomhet med beslektet type aktivitet.
Address
Sørkedalsveien 10A, 0369 Oslo
Phone
+4723292100
Email
hei@agilhelse.no
Website
www.agilhelse.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 18 116 | 27 642 | 22 110 | 21 263 | 21 962 |
| Staff expenses | −14 904 | −17 752 | −17 018 | −14 990 | −17 974 |
| EBITDA | −3 470 | 1 692 | −3 168 | −199 | −3 788 |
| Depreciation & amort. | −575 | −378 | −473 | −272 | −98 |
| EBIT | −4 045 | 1 314 | −3 641 | −471 | −3 885 |
| Net financials | −78 | −84 | −153 | −268 | −418 |
| Profit before tax | −4 123 | 1 230 | −3 794 | −739 | −4 304 |
| Tax | −699 | 500 | −834 | −69 | −960 |
| Net profit | −3 424 | 730 | −2 960 | −669 | −3 344 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 6 817 | 8 975 | 7 398 | 8 034 | 7 512 |
| Equity | −3 424 | 2 444 | −516 | −185 | −5 785 |
| Long-term debt | 6 791 | 2 026 | 4 391 | 4 260 | 5 394 |
| Short-term debt | 3 451 | 4 505 | 3 523 | 3 959 | 7 903 |
| Total debt | 10 242 | 6 531 | 7 914 | 8 219 | 13 297 |
EBITDA margin
-17.2%
This company
15.8%
Market median
-209% vs market
20202024
Equity ratio
-77.0%
This company
38.2%
Market median
-302% vs market
20202024
Return on equity
-334423300.0%
This company
18.4%
Market median
-1817518035% vs market
20202024
Net profit margin
-15.2%
This company
8.1%
Market median
-288% vs market
20202024
Asset turnover
2.92×
This company
1.12×
Market median
+161% vs market
20202024
Debt / equity
2.30×
This company
0.62×
Market median
-271% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AG Chief Executive Officer | Chief Executive Officer | 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2025 | |
| Chairman | 2020 | |
| Board of Directors | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 51% | 51% | 2024 | |
| Company | 49% | 49% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Stilar Holding As
AGIL HELSE AS Board members of AGIL HELSE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| André Glomsvoll | Chief Executive Officer | 0 companies |
| Elsa Solheim Braadland | Board of Directors | 0 companies |
| Bjørn Wahl | Chairman | 0 companies |
| Stian Larsen | Board of Directors | 0 companies |